{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:43Z","timestamp":1786119163185,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/wco.0b013e3282f22ad9","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T19:15:53Z","timestamp":1236107753000},"page":"699-703","source":"Crossref","is-referenced-by-count":22,"title":["Therapies for narcolepsy with or without cataplexy: evidence-based review"],"prefix":"10.1097","volume":"20","author":[{"given":"Susan","family":"Keam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210206","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-1331.2006.01473.x","article-title":"EFNS guidelines on management of narcolepsy","volume":"13","author":"Billiard","year":"2006","journal-title":"European Journal of Neurology"},{"key":"R2-17-20210206","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"R4-17-20210206","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/14728214.9.2.281","article-title":"Emerging drugs for narcolepsy","volume":"9","author":"Abad","year":"2004","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"R5-17-20210206","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00023210-200721040-00007","article-title":"Sodium oxybate: a review of its use in the management of narcolepsy","volume":"21","author":"Robinson","year":"2007","journal-title":"CNS Drugs"},{"key":"R6-17-20210206","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/sleep\/30.1.13","article-title":"The epidemiology of narcolepsy","volume":"30","author":"Longstreth","year":"2007","journal-title":"Sleep"},{"key":"R7-17-20210206","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0404.2006.00594.x","article-title":"Health-related quality of life in narcolepsy","volume":"114","author":"Ervik","year":"2006","journal-title":"Acta Neurologica Scandinavica"},{"key":"R8-17-20210206","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.sleep.2007.03.004","article-title":"Therapeutic advances in narcolepsy","volume":"8","author":"Thorpy","year":"2007","journal-title":"Sleep Medicine"},{"key":"R9-17-20210206","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.smrv.2004.01.004","article-title":"Pharmacotherapy for cataplexy","volume":"8","author":"Houghton","year":"2004","journal-title":"Sleep Medicine Reviews"},{"key":"R10-17-20210206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00023210-200620010-00004","article-title":"Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management","volume":"20","author":"Thorpy","year":"2006","journal-title":"CNS Drugs"},{"key":"R11-17-20210206","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","article-title":"Sodium oxybate improves excessive daytime sleepiness in narcolepsy","volume":"29","author":"Black","year":"2006","journal-title":"Sleep"},{"key":"R12-17-20210206","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079906X100050","article-title":"The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy","volume":"22","author":"Harsh","year":"2006","journal-title":"Current Medical Research & Opinion"},{"key":"R13-17-20210206","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-2003-41200","article-title":"Ritanserin improves sleep quality in narcolepsy","volume":"36","author":"Mayer","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"R14-17-20210206","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/sleep\/24.4.385","article-title":"A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy","volume":"24","author":"Rogers","year":"2001","journal-title":"Sleep"},{"key":"R15-17-20210206","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00213-002-1343-4","article-title":"Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies","volume":"167","author":"Thorpy","year":"2003","journal-title":"Psychopharmacology"},{"key":"R16-17-20210206","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy.","volume":"54","year":"2000","journal-title":"Neurology"},{"key":"R17-17-20210206","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410430115","article-title":"Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy.","volume":"43","year":"1998","journal-title":"Annals of Neurology"},{"key":"R18-17-20210206","first-page":"42","article-title":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.","volume":"25","year":"2002","journal-title":"Sleep"},{"key":"R19-17-20210206","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/sleep\/29.9.1189","article-title":"A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy","volume":"29","author":"Weaver","year":"2006","journal-title":"Sleep"},{"key":"R20-17-20210206","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5664\/jcsm.26368","article-title":"A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. [see comment].","volume":"1","year":"2005","journal-title":"Journal of Clinical Sleep Medicine"},{"key":"R21-17-20210206","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.sleep.2005.03.010","article-title":"Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.[see comment].","volume":"6","year":"2005","journal-title":"Sleep Medicine"},{"key":"R22-17-20210206","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00213-003-1508-9","article-title":"Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy","volume":"171","author":"Becker","year":"2004","journal-title":"Psychopharmacology"},{"key":"R24-17-20210206","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/sleep\/24.3.282","article-title":"Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: a pilot study","volume":"24","author":"Larrosa","year":"2001","journal-title":"Sleep"},{"key":"R25-17-20210206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/s1389-9457(02)00240-x","article-title":"Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants","volume":"4","author":"Schwartz","year":"2003","journal-title":"Sleep Medicine"},{"key":"R26-17-20210206","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1468-1331.2000.00087.x","article-title":"Problems associated with switch to modafinil - a novel alerting agent in narcolepsy","volume":"7","author":"Guilleminault","year":"2000","journal-title":"European Journal of Neurology"},{"key":"R27-17-20210206","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/sleep\/28.9.1189","article-title":"Atomoxetine also effective in patients suffering from narcolepsy?","volume":"28","author":"Niederhofer","year":"2005","journal-title":"Sleep"},{"key":"R28-17-20210206","first-page":"174","article-title":"Cataplexy treated with escitalopram\u2013clinical experience","volume":"27","author":"Sonka","year":"2006","journal-title":"Neuroendocrinology Letters"},{"key":"R30-17-20210206","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1389-9457(00)00031-9","article-title":"Long-term efficacy and safety of modafinil (PROVIGIL) for the treatment of excessive daytime sleepiness associated with narcolepsy","volume":"1","author":"Mitler","year":"2000","journal-title":"Sleep Med"},{"key":"R31-17-20210206","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/sleep\/22.6.757","article-title":"Health-related quality of life effects of modafinil for treatment of narcolepsy","volume":"22","author":"Beusterien","year":"1999","journal-title":"Sleep"},{"key":"R32-17-20210206","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.sleep.2003.11.002","article-title":"Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.","volume":"5","year":"2004","journal-title":"Sleep Medicine"},{"key":"R33-17-20210206","first-page":"31","article-title":"A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.","volume":"26","year":"2003","journal-title":"Sleep"},{"key":"R34-17-20210206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00002826-200005000-00004","article-title":"Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy","volume":"23","author":"Jasinski","year":"2000","journal-title":"Clinical Neuropharmacology"},{"key":"R35-17-20210206","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00002018-200427050-00002","article-title":"The Xyrem risk management program","volume":"27","author":"Fuller","year":"2004","journal-title":"Drug Safety"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WCO.0b013e3282f22ad9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:42:06Z","timestamp":1786038126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019052-200712000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e3282f22ad9","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}